gentian violet has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, B; Huang, X; Liu, X; Xu, B | 1 |
| Bao, GQ; Pan, CP; Peng, CH; Shen, BY; Shi, MM; Zhang, YJ | 1 |
2 other study(ies) available for gentian violet and Pancreatic Neoplasms
| Article | Year |
|---|---|
Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cytokines; Flow Cytometry; Genes, Reporter; Genetic Therapy; Gentian Violet; In Situ Nick-End Labeling; Interferon-gamma; Interleukins; Mice; Oncolytic Virotherapy; Pancreatic Neoplasms; T-Lymphocytes; Tetrazolium Salts; Thiazoles | 2013 |
Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Count; Cell Cycle; Cell Line, Tumor; Coloring Agents; Cytochromes c; Deoxycytidine; Diterpenes; Drug Synergism; Flow Cytometry; Gemcitabine; Gentian Violet; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2013 |